China-EU Exchange: COVID-19 Perspectives From the Frontlines on Patient and Hospital Management
Published: 16 April 2020
This webinar was developed by a collaboration between Boston Scientific, the British Cardiovascular Intervention Society (BCIS) and supported by Millbrook Medical Conferences and Radcliffe Cardiology. It brings together leading physicians from China and the UK with the aim to share knowledge, experience and learnings of the COVID-19 pandemic, including in-depth discussion regarding its characteristics, and management for its prevention and control.
- Understand the Approaches Taken for Infection Management in China
- Compare and Contrast Strategies for Management in Both the Wider Population and in a Clinical Setting
- To Enhance Knowledge of Treatment Strategies and Options Available
More from this programme
Clinical Characteristics and Management
Dr Liang Dong, 2nd Affiliated Hospital, Zhejiang University, Hangzhou, CN
Prof. Nick Curzen BM(hons) PhD FRCP is Professor of Interventional Cardiology at University of Southampton and Honorary Consultant Cardiologist at University Hospital Southampton NHS Foundation Trust. He is the current President of BCIS, having previously been a Council member, Education Lead, Research Lead and Honorary Secretary.
Nick specialises in coronary and aortic valve intervention.
He pursues an active research programme: Chief Investigator for RIPCORD2 and FORECAST randomised trials as well as for FFRCT RIPCORD & COMET. He also has active interests in platelet function, computer modelling of coronary stents and re-do TAVI implantation and coronary physiology. The research group contributes to many high profile multicentre trials. Nick has published over 320 PubMed papers and has edited 3 textbooks, including the Oxford Textbook of Interventional Cardiology.
Prof Curzen is an editorial board…
Prof Junbo Ge, Academician of the Chinese Academy of Sciences, and Zhongshan Hospital, Fudan University, Shanghai, CN